Diagnostic Blood Loss in the Patient Undergoing Head and Neck Surgery

Jack C. Borders, David W. Eisele, C. Alan Lyles

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To examine retrospectively the amount of blood lost solely for diagnostic purposes in a defined group of patients. Design: Retrospective medical chart review of a case series. Setting: Operating theater and surgical intensive care unit in a major tertiary care center. Patients: Thirty-nine consecutive patients with head and neck cancer undergoing major surgical procedures and requiring overnight intensive care unit monitoring. Main Outcome Measures: Patient medical records were analyzed for procedure, starting hematocrit reading, intraoperative estimated blood loss and intravenous fluids, operative time, history of blood product transfusion, blood lost for each phlebotomy encounter, and the immediate cost therefrom. Results: The mean diagnostic blood loss was 181 mL, which was 36% of estimated blood loss. In the group of 23 nontransfused patients, the average drop in hematocrit was 9.7%. This change in hematocrit correlated most strongly with operating time (P<.02) and the amount of intraoperative intravenous fluid administration (P<.05). The average cost to the patient directly from phlebotomyassociated charges was $542. Conclusions: Diagnostic blood loss contributes significantly to the overall blood loss in the patient undergoing head and neck surgery.

Original languageEnglish (US)
Pages (from-to)707-710
Number of pages4
JournalArchives of Otolaryngology--Head and Neck Surgery
Volume120
Issue number7
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Neck
Head
Hematocrit
Intensive Care Units
Costs and Cost Analysis
Phlebotomy
Critical Care
Operative Time
Head and Neck Neoplasms
Tertiary Care Centers
Blood Transfusion
Intravenous Administration
Medical Records
Reading
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Diagnostic Blood Loss in the Patient Undergoing Head and Neck Surgery. / Borders, Jack C.; Eisele, David W.; Lyles, C. Alan.

In: Archives of Otolaryngology--Head and Neck Surgery, Vol. 120, No. 7, 01.01.1994, p. 707-710.

Research output: Contribution to journalArticle

Borders, Jack C. ; Eisele, David W. ; Lyles, C. Alan. / Diagnostic Blood Loss in the Patient Undergoing Head and Neck Surgery. In: Archives of Otolaryngology--Head and Neck Surgery. 1994 ; Vol. 120, No. 7. pp. 707-710.
@article{a4206ab302a740e4a1565aee1328be6a,
title = "Diagnostic Blood Loss in the Patient Undergoing Head and Neck Surgery",
abstract = "Objective: To examine retrospectively the amount of blood lost solely for diagnostic purposes in a defined group of patients. Design: Retrospective medical chart review of a case series. Setting: Operating theater and surgical intensive care unit in a major tertiary care center. Patients: Thirty-nine consecutive patients with head and neck cancer undergoing major surgical procedures and requiring overnight intensive care unit monitoring. Main Outcome Measures: Patient medical records were analyzed for procedure, starting hematocrit reading, intraoperative estimated blood loss and intravenous fluids, operative time, history of blood product transfusion, blood lost for each phlebotomy encounter, and the immediate cost therefrom. Results: The mean diagnostic blood loss was 181 mL, which was 36{\%} of estimated blood loss. In the group of 23 nontransfused patients, the average drop in hematocrit was 9.7{\%}. This change in hematocrit correlated most strongly with operating time (P<.02) and the amount of intraoperative intravenous fluid administration (P<.05). The average cost to the patient directly from phlebotomyassociated charges was $542. Conclusions: Diagnostic blood loss contributes significantly to the overall blood loss in the patient undergoing head and neck surgery.",
author = "Borders, {Jack C.} and Eisele, {David W.} and Lyles, {C. Alan}",
year = "1994",
month = "1",
day = "1",
doi = "10.1001/archotol.1994.01880310013003",
language = "English (US)",
volume = "120",
pages = "707--710",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Diagnostic Blood Loss in the Patient Undergoing Head and Neck Surgery

AU - Borders, Jack C.

AU - Eisele, David W.

AU - Lyles, C. Alan

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Objective: To examine retrospectively the amount of blood lost solely for diagnostic purposes in a defined group of patients. Design: Retrospective medical chart review of a case series. Setting: Operating theater and surgical intensive care unit in a major tertiary care center. Patients: Thirty-nine consecutive patients with head and neck cancer undergoing major surgical procedures and requiring overnight intensive care unit monitoring. Main Outcome Measures: Patient medical records were analyzed for procedure, starting hematocrit reading, intraoperative estimated blood loss and intravenous fluids, operative time, history of blood product transfusion, blood lost for each phlebotomy encounter, and the immediate cost therefrom. Results: The mean diagnostic blood loss was 181 mL, which was 36% of estimated blood loss. In the group of 23 nontransfused patients, the average drop in hematocrit was 9.7%. This change in hematocrit correlated most strongly with operating time (P<.02) and the amount of intraoperative intravenous fluid administration (P<.05). The average cost to the patient directly from phlebotomyassociated charges was $542. Conclusions: Diagnostic blood loss contributes significantly to the overall blood loss in the patient undergoing head and neck surgery.

AB - Objective: To examine retrospectively the amount of blood lost solely for diagnostic purposes in a defined group of patients. Design: Retrospective medical chart review of a case series. Setting: Operating theater and surgical intensive care unit in a major tertiary care center. Patients: Thirty-nine consecutive patients with head and neck cancer undergoing major surgical procedures and requiring overnight intensive care unit monitoring. Main Outcome Measures: Patient medical records were analyzed for procedure, starting hematocrit reading, intraoperative estimated blood loss and intravenous fluids, operative time, history of blood product transfusion, blood lost for each phlebotomy encounter, and the immediate cost therefrom. Results: The mean diagnostic blood loss was 181 mL, which was 36% of estimated blood loss. In the group of 23 nontransfused patients, the average drop in hematocrit was 9.7%. This change in hematocrit correlated most strongly with operating time (P<.02) and the amount of intraoperative intravenous fluid administration (P<.05). The average cost to the patient directly from phlebotomyassociated charges was $542. Conclusions: Diagnostic blood loss contributes significantly to the overall blood loss in the patient undergoing head and neck surgery.

UR - http://www.scopus.com/inward/record.url?scp=0028246163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028246163&partnerID=8YFLogxK

U2 - 10.1001/archotol.1994.01880310013003

DO - 10.1001/archotol.1994.01880310013003

M3 - Article

VL - 120

SP - 707

EP - 710

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 7

ER -